MedTrace Logo

Association Between Vitamin D and the Risk of Uterine Fibroids

NCT03586947 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1160

Last updated 2018-09-05

No results posted yet for this study

Summary

The aim of this randomised clinical trial study is to evaluate whether supplementation with vitamin D could reduce the risk of uterine fibroids in reproductive stage women.

Conditions

  • Gynaecological Disease
  • Vitamin D Deficiency
  • Uterine Fibroids

Interventions

DRUG

Vitamin D3 400 UNT Oral Capsule

50,000 IU of vitamin D once a week for 8 weeks, 1500-2000 IU/day.

Sponsors & Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2021-01-01
Completion
2021-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03586947 on ClinicalTrials.gov